Physician profile
James Tagle
NPI 1255677597
$2,044.64
in general payments reported to CMS, 2019-2025
19 companies · $771 in 2025
The $771 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $421 · 2024: $730 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $439.20 | 2024-2025 | Micra, Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $308.77 | 2022-2024 | Flexability, Ensite |
| Astrazeneca Pharmaceuticals LP | $238.99 | 2023-2025 | Wainua, Farxiga |
| Novartis Pharmaceuticals Corporation | $170.43 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.42 | 2024-2025 | Lifevest |
| Pfizer INC. | $122.11 | 2022-2024 | |
| Novo Nordisk INC | $91.40 | 2025 | Wegovy, Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $84.04 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.42 | 2023-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $69.05 | 2022-2024 | Verquvo |
| Boston Scientific Corporation | $62.30 | 2023 | Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $55.28 | 2022-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals International, Plc | $45.10 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $34.66 | 2022-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $21.38 | 2023 | Inpefa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $18.14 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $16.82 | 2023 | |
| Baxter Healthcare | $15.94 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $14.19 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.